Effect of FK506 on cytokine secretion in whole blood.
- Author:
He YI
1
;
Li MIN
;
Zhan-guo LIU
;
Yu-wei LUO
;
Ming WANG
;
Jie ZHANG
;
Er-wei SUN
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Cytokines; blood; secretion; Down-Regulation; drug effects; Female; Humans; Immunosuppressive Agents; pharmacology; Interferon-gamma; blood; secretion; Interleukin-6; blood; secretion; Male; Tacrolimus; pharmacology; Tumor Necrosis Factor-alpha; blood; secretion; Young Adult
- From: Journal of Southern Medical University 2010;30(2):249-251
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effect of FK506 on cytokine secretions in whole blood from healthy individuals.
METHODSBlood samples collected from healthy volunteers were co-cultured with different concentrations of FK506 and stimulated with PMA and IONO. The concentrations of 8 cytokines including IL-2, IL-6, IL-12, IL-17, IFN-gamma, TNF-alpha, GM-CSF and G-CSF were detected by Bio-Plex suspension system.
RESULTSCompared with the control group, high-concentration FK506 (20 ng/ml) significantly inhibited the secretions of IL-2, IL-6, IL-12, IL-17, IFN-gamma, TNF-alpha, GM-CSF and G-CSF. At a moderate concentration (5 ng/ml), FK506 inhibited the secretion of GM-CSF significantly.
CONCLUSIONFK506 effectively inhibits the secretion of proinflammatory cytokines including IL-6, IFN-gamma and TNF-alpha and also the secretion of IL-2, IL-12, IL-17, GM-CSF and G-CSF. FK506 might play the role of immunosuppression by inhibiting the production of these cytokines by the immune cells. Monitoring the levels of these cytokines might be a potential method for evaluating the adequacy of FK506 doses administered.